Profound Medical Company Executives
| PRN Stock | CAD 7.54 -0.05 -0.66% |
Profound Medical employs about 162 people. The company is managed by 10 executives with a total tenure of roughly 378 years, averaging almost 37.0 years of service per executive, having 16.2 employees per reported executive. For Profound Medical Corp, management analysis can help investors test whether leadership decisions are reinforcing the broader investment thesis or creating new operating risk. Used properly, management analysis helps separate durable execution from results that may only reflect a supportive market cycle.
Profound |
Profound Medical Management Team Effectiveness
The company has return on total asset (ROA) of -34.91 % which means that it is not converting its asset base into profit. This is a lagging result relative to sector standards. Similarly, it shows a return on equity (ROE) of -67.11 %, which means that it produced no profit with money invested by stockholders.As of March 2026, Common Stock Shares Outstanding is projected to decline to approximately 15.5 M. In addition to that, Net Loss is projected to decline to approximately -26.3 M
Stock Ownership Analysis
About 45.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.79. Profound Medical Corp last dividend was issued on the 16th of October 2019. The company completed a 1:10 stock split on 16th of October 2019.Outstanding Bonds
Reviewing Profound Medical Corp bond obligations helps investors understand how much of the business is financed with fixed-income capital rather than purely with equity. This is why bond analysis is not just a credit exercise; it also informs equity holders about solvency, optionality, and future capital-allocation pressure.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Shares in Circulation | First Issued 2014-03-31 | Previous Quarter 30.1 M | Current Value 30.7 M | Average Shares Outstanding 14.4 M | Quarterly Volatility 9.3 M |
Macro event markers
Profound Stock Holders Distribution
Institutional ownership analysis for Profound Medical Corp matters because banks, hedge funds, pension plans, and other professional investors can influence price and liquidity more forcefully than smaller holders. This matters because getting in early on a sponsorship cycle may help, but getting caught near a large-holder exit can have the opposite effect.
Profound Medical Market Cap and Value
Profound Medical Workforce Comparison
Profound Medical Corp lands at #4 in number of employees compared to key competitors. The total workforce of Health Care industry is at this time estimated at about 3,598. Profound Medical holds roughly 162 in number of employees claiming about 5% of equities under Health Care sector.
Profound Medical Profit Margins
The company has Profit Margin (PM) of -2.64 %, which may indicate poor execution on it's competitive strategy. This is a lagging result relative to sector standards. Similarly, it shows Operating Margin (OM) of -1.23 %, which implies that for every 100 dollars of sales, it incurs a net operating loss of $1.23.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.41 | 0.7077 |
|
|
Profound Medical Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Profound Medical Corp Price Series Summation is a cross summation of Profound Medical price series and its benchmark/peer.
Profound Medical Notable Stakeholders
Stakeholders matter for Profound Medical because not every influential participant is a shareholder acting with the same objective or time horizon. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.
| Arun MBA | Chairman CEO | Profile | |
| Hartmut Warnken | Senior Alliances | Profile | |
| Jacques Cornet | Senior Sonalleve | Profile | |
| Stephen Kilmer | Investor Relations | Profile | |
| Mathieu Burtnyk | Senior TULSAPRO | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Abbey Goodman | Chief Global | Profile | |
| Levant Tinaz | Software Developer | Profile | |
| Michael Mydra | VP Access | Profile | |
| Rashed Dewan | Chief Officer | Profile |
Management Information & Data Sources
Profound Medical is a micro-cap company in Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care. Executive review focuses on insiders, senior management, and employee signals. Changes in insider ownership can offer context, but they should be read with fundamentals and market conditions. CEO is Arun MBA with 162 employees and 10 reported executives.
For Profound Medical Corp, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Intraday timing differences may exist. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Investors reviewing Profound Medical Corp can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.
Profound Medical Manpower Efficiency
Return on Profound Medical Manpower
| Revenue Per Employee | 138.8K | |
| Revenue Per Executive | 2.2M | |
| Net Loss Per Employee | 367.2K | |
| Net Loss Per Executive | 5.9M | |
| Working Capital Per Employee | 385.8K | |
| Working Capital Per Executive | 6.2M |
More Resources for Profound Stock Analysis
A comprehensive view of Profound Medical Corp starts with financial statements and ratio context. Financial ratios provide context for profitability, efficiency, and growth trends. Outlined below are key reports that provide context for Profound Medical Corp Stock:Profound Medical has a market cap of 275.46 M, operating margin of -123.29%, ROE of -67.11%. See Your Equity Center for portfolio-level analysis. This suggests a position in Profound Medical Corp within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. Analysis related to Profound Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..